Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 2 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Head-to-head comparison of three chelates reveals DOTAGA promising for 225 Ac labeling of anti-FZD10 antibody OTSA101.
Cancer Sci. 2023 Dec;114(12):4677-4690. doi: 10.1111/cas.15978. Epub 2023 Oct 2.
Cancer Sci. 2023.
PMID: 37781962
Free PMC article.
FZD10-targeted α-radioimmunotherapy with 225 Ac-labeled OTSA101 achieves complete remission in a synovial sarcoma model.
Sudo H, Tsuji AB, Sugyo A, Harada Y, Nagayama S, Katagiri T, Nakamura Y, Higashi T.
Sudo H, et al.
Cancer Sci. 2022 Feb;113(2):721-732. doi: 10.1111/cas.15235. Epub 2021 Dec 21.
Cancer Sci. 2022.
PMID: 34935247
Free PMC article.
Item in Clipboard
Preclinical Evaluation of Podoplanin-Targeted Alpha-Radioimmunotherapy with the Novel Antibody NZ-16 for Malignant Mesothelioma.
Sudo H, Tsuji AB, Sugyo A, Kaneko MK, Kato Y, Nagatsu K, Suzuki H, Higashi T.
Sudo H, et al.
Cells. 2021 Sep 22;10(10):2503. doi: 10.3390/cells10102503.
Cells. 2021.
PMID: 34685483
Free PMC article.
Item in Clipboard
Cite
Cite